Medicine

August 14, 2017

Risk Assessment Methods

Over the past 10 days, I have posted on HI-Blog relating to the recent suspension of the certification of PEAK Analytics to test State-legal Cannabis in Washington. Those posts and subsequent communications have alerted the WSLCB, the public, and industry participants to the exposure risk stemming from the continued availability of PEAK-tested product in Retail Access Points. They also allude to the non-zero risk of morbidity and mortality associated with such exposure. Some of the comments I’ve seen relating to my work regarding PEAK’s inadequacy in testing for “Total Coliforms” […]
August 12, 2017

PSA #8: Patients can now almost fill a stadium

As of this past Wed. (Aug. 9), the Washington State Dept. of Health has released data which indicate that over 25,000 people are now in their patient registration database. If you ever want an update on how the regulated medical infrastructure is rolling out (now 13+ months into it’s infancy), check out the DOH Statistics and Data page here In the meanwhile, here is what the DOH has to say, followed by a tiny bit of context-setting, courtesy of moi. . This represents 0.35% of all Washingtonians (or 1 in […]
July 25, 2017

Where to Find Terpestival Winners – Top Retail Access Points

Last Saturday, CASP (The Cannabis & Social Policy Center) put on the 3rd annual Terpestival in Seattle down in SODO. – with the help of the wonderful Lara Kaminsky and a growing rank of helpers and sponsors of this most worthy non-profit. Flower samples and concentrate samples were evaluated using a combination of the levels of key Terpenes (quantified by the more-ISO-certified-than-most Medicine Creek Analytics) and the subjective ratings of quality by a panel of knowledgeable judges (flavor/taste/effect-type quality). A number of awards were given in various categories (including a […]
July 22, 2017

Identifying Patient-Killing Frankenstein Stores: First Steps

Based on the data from the first year of Washington’s Regulated Medical Cannabis System, my assumption that the Patient Protection Act (SSB-5052) of 2015 would actually protect those Washingtonians who depend on Cannabis or Cannabinoid-containing products as part of their medicine/supplement regime was clearly wrong. See a summary of the state of the thing that our Legislators and Regulators call Medical Cannabis that I recently published on HI-Blog . I’ve spent a good deal of time pondering the reason(s) why the adoption of the regulated medical system by Patients, the […]